Collegium Pharmaceutical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US19459J1043
USD
47.43
-0.08 (-0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
631.45
566.77
463.93
276.87
310.02
296.70
280.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
631.45
566.77
463.93
276.87
310.02
296.70
280.41
Raw Material Cost
254.10
240.60
252.34
127.99
130.18
193.66
165.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
73.97
83.34
63.21
21.01
28.88
0.91
20.13
Selling and Distribution Expenses
186.03
150.71
140.89
116.03
113.83
116.45
126.76
Other Expenses
-7.40
-8.33
-6.19
-1.33
-1.91
0.94
-1.15
Total Expenditure (Excl Depreciation)
440.14
391.31
394.53
251.73
253.78
320.45
301.10
Operating Profit (PBDIT) excl Other Income
191.29999999999998
175.5
69.4
25.099999999999998
56.2
-23.700000000000003
-20.7
Other Income
13.98
15.62
1.05
0.01
0.23
1.94
1.69
Operating Profit (PBDIT)
374.45
340.33
204.84
94.09
118.07
-6.02
91.91
Interest
73.97
83.34
63.21
21.01
28.88
0.91
20.13
Exceptional Items
-32.74
-32.00
-36.08
-7.51
0.00
0.00
0.00
Gross Profit (PBDT)
377.34
326.17
211.59
148.88
179.84
103.04
114.74
Depreciation
169.16
149.26
134.39
68.94
61.61
15.80
110.91
Profit Before Tax
98.57
75.73
-28.85
-3.37
27.58
-22.72
-39.13
Tax
29.38
27.58
-3.85
-74.89
0.83
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.19
48.16
-25.00
71.52
26.75
-22.72
-39.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.19
48.16
-25.00
71.52
26.75
-22.72
-39.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
69.19
48.16
-25.00
71.52
26.75
-22.72
-39.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
228.84
195.43
194.84
202.93
186.03
87.43
91.58
Earnings per share (EPS)
1.86
1.29
-0.74
1.86
0.76
-0.68
-1.19
Diluted Earnings per share
1.86
1.29
-0.74
1.86
0.76
-0.68
-1.19
Operating Profit Margin (Excl OI)
30.3%
30.96%
14.96%
9.08%
18.14%
-8.0%
-7.38%
Gross Profit Margin
42.4%
39.7%
22.75%
23.68%
28.77%
-2.33%
25.6%
PAT Margin
10.96%
8.5%
-5.39%
25.83%
8.63%
-7.66%
-13.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 11.40% vs 22.18% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 43.57% vs 292.80% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 11.03% vs 59.32% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -11.16% vs 31.80% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Collegium Pharmaceutical, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
631.45
372.51
258.94
69.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
631.45
372.51
258.94
69.51%
Raw Material Cost
254.10
76.45
177.65
232.37%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
73.97
22.21
51.76
233.05%
Selling and Distribution Expenses
186.03
115.54
70.49
61.01%
Other Expenses
-7.40
-0.86
-6.54
-760.47%
Total Expenditure (Excl Depreciation)
440.14
205.64
234.50
114.03%
Operating Profit (PBDIT) excl Other Income
191.31
166.87
24.44
14.65%
Other Income
13.98
16.14
-2.16
-13.38%
Operating Profit (PBDIT)
374.45
222.86
151.59
68.02%
Interest
73.97
22.21
51.76
233.05%
Exceptional Items
-32.74
-123.41
90.67
73.47%
Gross Profit (PBDT)
377.34
296.06
81.28
27.45%
Depreciation
169.16
39.85
129.31
324.49%
Profit Before Tax
98.57
37.39
61.18
163.63%
Tax
29.38
14.00
15.38
109.86%
Provisions and contingencies
0
0
0.00
Profit After Tax
69.19
23.39
45.80
195.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
69.19
23.39
45.80
195.81%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
69.19
23.39
45.80
195.81%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
228.84
691.16
-462.32
-66.89%
Earnings per share (EPS)
1.86
0.36
1.50
416.67%
Diluted Earnings per share
1.86
0.36
1.50
416.67%
Operating Profit Margin (Excl OI)
30.30%
44.80%
0.00
-14.50%
Gross Profit Margin
42.40%
20.74%
0.00
21.66%
PAT Margin
10.96%
6.28%
0.00
4.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 63.14 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.40% vs 22.18% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 6.92 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 43.57% vs 292.80% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.03% vs 59.32% in Dec 2023

Annual - Interest
Interest 7.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -11.16% vs 31.80% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.30%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023